Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells

Cytokine

Volumn 46, Issue 1, 2009, Pages 72-78

  Safaya, Surinder ^a   Klings, Elizabeth S ^a   Odhiambo, Adam ^a   Li, Guihua ^a   Farber, Harrison W ^a   Steinberg, Martin H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Butyrate; Endothelium; Inflammation; Sickle cell disease; TNF

Indexed keywords

BUTYRIC ACID; CIS ACTING ELEMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ARTERY ENDOTHELIUM; ARTICLE; CELL TYPE; CONSENSUS SEQUENCE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; PROMOTER REGION; PULMONARY ARTERY;

CELL LINE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; LUNG; MICROCIRCULATION; MODELS, BIOLOGICAL; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PULMONARY ARTERY; SODIUM OXYBATE; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62749197294     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.12.013     Document Type: Article

References (35)

1. Hammerman S.I., Klings E.S., Hendra K.P., Upchurch Jr. G.R., Rishikof D.C., Loscalzo J., et al. Endothelial cell nitric oxide production in acute chest syndrome. Am J Physiol Heart Circ Physiol 277 (1999) H1579-H1592
2. Shiu Y.T., Udden M.M., and McIntire L.V. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells. Blood 95 (2000) 3232-3241
3. Hammerman S.I., Kourembanas S., Conca T.J., Tucci M., Brauer M., and Farber H.W. Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 156 (1997) 280-285
4. Yu J., Tian S., Metheny-Barlow L., Chew L.-J., Hayes A.J., Pan H., et al. Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor. Circ Res 89 (2001) 1161-1167
5. Kang Y.-J., Kim W.-J., Bae H.-U.k., Kim D.I.-k., Park Y.B., Park J.-E., et al. Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine 29 (2005) 229-235
6. Prehn J.L., Mehdizadeh S., Landers C.J., Luo X., Cha S.C., Wei P., et al. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-γ, in mucosal inflammation. Clin Immunol 112 (2004) 66-77
7. Bamias G., Mishina M., Nyce M., Ross W.G., Kollias G., Nieves J.R., et al. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc Natl Acad Sci USA 103 (2006) 8441-8446
8. Migone T.-S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T-cell costimulator. Immunity 16 (2002) 479-492
9. Pober J., and Cotran R. The role of endothelial cells in inflammation. Transplantation 50 (1990) 537-544
10. Hebbel R.P., Osarogiagbon U.R., and Kaul D. The endothelial biology of Sickle cell disease: inflammation and chronic vasculopathy. Microcirculation 11 (2004) 129-152
11. Perrine S.P., and Faller D.V. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies. Experientia 49 (1993) 133-137
12. Safaya S., Ibrahim A., and Rieder R.F. Augmentation of γ-globin gene promoter activity by carboxylic acids and components of the human β-globin locus control region. Blood 84 (1994) 3929-3935
13. Miller S.J., Zaloga G.P., Hoggatt A.M., Carlos L.C., and Faulk W.P. Short-chain fatty acids modulate gene expression for vascular endothelial cell adhesion molecules. Nutrition 21 (2005) 740-748
14. Odièvre M.H., Brun M., Krishnamoorthy R., Lapouméroulie C., and Elion J. Sodium phenylbutyrate down regulates endothelin-1 expression in cultured human endothelial cells: relevance to sickle-cell disease. Am J Hematol 82 (2007) 357-362
15. Saemann M.D., Bohmig G.A., Österreicher C.H., Burtscher H., Parolini O., Diakos C., et al. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL 12 and up-regulation of IL-10 production. FASEB J 14 (2000) 2380-2382
16. Shimizu K., Watanabe K., Yamashita H., Abe M., Yoshimatsu H., Ohta H., et al. Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells. Biochem Biophys Res Commun 327 (2005) 700-706
17. Lui W.-Y., Sze K.-L., and Lee W.M. Nectin-2 expression in testicular cells is controlled via the functional cooperation between transcription factors of the Sp1, CREB, and AP-1 families. J Cell Physiol 207 (2006) 144-157
18. Marreirosa A., Czolijc R., Yardleya G., Crossleyc M., and Jackson P. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53. Gene 302 (2003) 155-164
19. Ganster R.W., Taylor B.S., Shao L., and Geller D.A. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci USA 98 (2001) 8638-8643
20. Yutaka K., Shimizu T., and Kuwano K. Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line, EBC-1. Mol Immunol 43 (2006) 1972-1981
21. Walker G.E., Wilson E.M., Powell D., and Oh Y. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves anSp1/Sp3 multiprotein complex. Endocrinology 142 (2001) 3817-3827
22. Ye J., Shedd D., and Miller G. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J Virol 79 (2005) 1397-1408
23. Patel P., Nankova B.B., and LaGamma E.F. Butyrate, a gut-derived environmental signal, regulates tyrosine hydroxylase gene expression via a novel promoter element. Dev Brain Res 160 (2005) 53-62
24. Yin L., Laevsky G., and Giardina C. Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J Biol Chem 276 (2001) 44641-44646
25. Yoo E.J., Chung J.J., Choe S.S., Kim K.H., and Kim J.B. Down-regulation of histone deacetylases stimulates adipocyte differentiation. J Biol Chem 281 (2006) 6608-6615
26. Xiao Q., Hsu C.Y., Chen H., Xiucui M.A., Xu J., and Lee J.-M. Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter. Biochem J 388 (2005) 913-920
27. Sebban H., and Courtois G. NF-κB and inflammation in genetic disease. Biochem Pharmacol 72 (2006) 1153-1160
28. Belcher J.D., Mahaseth H., Welch T.E., Vilback A.E., Sonbol K.M., Kalambur V.S., et al. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol 288 (2005) H2715-H2725
29. Mahaseth H., Vercellotti G.M., Welch T.E., Bowlin P.R., Sonbol K.M., Hsia C.J., et al. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice. J Lab Clin Med 145 (2005) 204-211
30. Setty B.N., and Stuart M.J. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 88 (1996) 2311-2320
31. Kaul D.K., Fabrey M.E., and Nagel R.L. The pathophysiology of vascular obstruction in the sickle syndrome. Blood Rev 10 (1996) 29-44
32. Platt O.S. Sickle cell anemia as an inflammatory disease. J Clin Invest 106 (2000) 337-338
33. Kaul D.K., Liu X.D., Choong S., Belcher J.D., Vercellotti G.M., and Hebbel R.P. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am J Physiol Heart Circ Physiol 287 (2004) H293-H301
34. Okpala I. Leukocyte adhesion and the pathophysiology of sickle cell disease. Curr Opin Hematol 13 (2006) 40-44
35. Covas D.T., de Lucena Angulo I., Vianna Bonini P.P., and Zago M.A. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia. Haematologica 89 (2004) 273-280